The Centers for Disease Control and Prevention (CDC) is seeking public comment for updating the Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings (2006).
The purpose of this process is to solicit feedback on the best approaches for HIV screening in clinical settings and prompt linkage to treatment and care. CDC will update the guidelines to ensure that HIV testing providers, public health agencies, and other stakeholders have access to up-to-date and consistent information about new evidence, current approaches, and resources for HIV testing in clinical settings.
CDC invites comments specifically on opt-out routine HIV testing, including, but not limited to:
- Suggestions for revisions, edits, and new additions
- Contemporary issues and new evidence
- Implementation barriers, challenges, and lessons learned
- Examples of innovative models, partnerships, and collaborations
The deadline to comment is October 28, 2019.
Comments can be submitted electronically via the Federal eRulemaking portal.
Comments can also be submitted by mail to: DHAP Guideline Team, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS D21, Atlanta, Georgia 30329. All submissions must include the agency name (Centers for Disease Control and Prevention) and Docket No. CDC-2019-0069.
All relevant comments received will be posted without change, including personal information. These comments, including attachments and other supporting materials, are part of the public record and are subject to public disclosure.